Physician profile
Jack P Ayoub
NPI 1790836690
$279,164.58
in general payments reported to CMS, 2019-2025
35 companies · $582 in 2025
The $582 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172K · 2020: $39K · 2021: $39K · 2022: $7,057 · 2023: $2,971 · 2024: $18K · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $3,849 · Food and Beverage: $2,689 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,400.00 |
| Travel and Lodging | $3,849.23 |
| Food and Beverage | $2,689.00 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $239,440.40 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Pfizer INC. | $28,734.90 | 2021-2024 | |
| Therapeuticsmd, INC. | $4,878.94 | 2019-2022 | |
| Myovant Sciences INC. | $1,848.19 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $686.07 | 2023-2025 | Myfembree, Gemtesa |
| Renovia INC | $647.86 | 2021 | |
| Intuitive Surgical, INC. | $632.28 | 2019-2023 | Da Vinci Surgical System |
| Mayne Pharma Commercial LLC | $411.98 | 2021-2025 | |
| Exeltis, USA INC. | $308.53 | 2019-2025 | Slynd |
| Avion Pharmaceuticals | $174.50 | 2019-2023 | Balcoltra |
| Aspira Women'S Health INC | $149.81 | 2022-2025 | Ova1 |
| Astellas Pharma US INC | $140.55 | 2019-2025 | Veozah |
| Myriad Women'S Health, INC. | $106.11 | 2023 | Myrisk |
| Exact Sciences Corporation | $105.23 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Baxter Healthcare | $99.56 | 2023 | Tisseel |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $96.18 | 2021-2023 | Summit Doppler |
| Evofem Biosciences, INC. | $80.17 | 2021-2022 | |
| Becton, Dickinson and Company | $80.10 | 2024 | Bd Max System, Bd Max Instrument |
| Minerva Surgical, INC | $64.26 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.59 | 2021-2025 | |
| Scynexis, INC. | $53.59 | 2022 | |
| Bausch Health US, LLC | $42.93 | 2025 | Aplenzin |
| Mylan Pharmaceuticals INC. | $40.55 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $37.74 | 2019-2020 | |
| Edwards Lifesciences Corporation | $37.23 | 2021 | |
| Organon LLC | $31.32 | 2022 | |
| Coala Life INC | $28.33 | 2023 | Coala Heart Monitor |
| Allergan, INC. | $23.87 | 2019 | |
| Millicent US INC | $22.45 | 2019 | |
| Sage Therapeutics, LLC | $20.95 | 2025 | Zurzuvae |
| Convatec INC. | $20.48 | 2024 | |
| Vertical Pharmaceuticals, LLC | $16.48 | 2019 | |
| Hologic Sales and Service, LLC | $15.67 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.22 | 2019 | |
| Duchesnay USA Incorporated | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Ayoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.